( in Million)
Particulars
Dec 2025
Sep 2025
Jun 2025
Mar 2025
Audited / UnAudited
UnAudited
UnAudited
UnAudited
UnAudited
Net Sales
601.05
690.8
688.38
631.77
Total Expenditure
523.14
618.08
610.16
563.45
PBIDT (Excl OI)
77.91
72.71
78.22
68.31
Other Income
14.71
14.99
15.09
15.54
Operating Profit
92.62
87.70
93.31
83.85
Exceptional Items
NA
1.4
NA
NA
Depreciation
46.11
44.53
42.97
42.89
Profit Before Tax
42.13
41.10
46.72
36.93
Provisions and contingencies
NA
NA
NA
NA
Profit After Tax
31.52
30.29
33.19
25.18
Extraordinary Items
NA
NA
NA
NA
Prior Period Expenses
NA
NA
NA
NA
Other Adjustments
NA
NA
NA
NA
Net Profit
31.52
30.29
33.19
25.18
Minority Interest
0.36
-1.69
-1.33
0.24
Misc. Expenses Written off
NA
NA
NA
NA
Consolidated Net Profit
31.86
28.61
31.86
25.43
Equity Capital
1083.19
1083.19
1083.19
1083.19
Calculated EPS
0.02
0.02
0.02
0.02
Calculated EPS (Annualised)
0.11
0.10
0.11
0.09
No of Public Share Holdings
649338642
649338642
649338642
649338642
% of Public Share Holdings
59.95
59.95
59.95
59.95
PBIDTM% (Excl OI)
12.96
10.52
11.36
10.81
PBIDTM%
15.40
12.69
13.55
13.27
PBDTM%
14.68
12.39
13.02
12.63